36 research outputs found

    The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data

    Get PDF
    Angiotensin-converting enzyme (ACE) is primarily localized (>90%) in various tissues and organs, most notably on the endothelium but also within parenchyma and inflammatory cells. Tissue ACE is now recognized as a key factor in cardiovascular and renal diseases. Endothelial dysfunction, in response to a number of risk factors or injury such as hypertension, diabetes mellitus, hypercholesteremia, and cigarette smoking, disrupts the balance of vasodilation and vasoconstriction, vascular smooth muscle cell growth, the inflammatory and oxidative state of the vessel wall, and is associated with activation of tissue ACE. Pathologic activation of local ACE can have deleterious effects on the heart, vasculature, and the kidneys. The imbalance resulting from increased local formation of angiotensin II and increased bradykinin degradation favors cardiovascular disease. Indeed, ACE inhibitors effectively reduce high blood pressure and exert cardio- and renoprotective actions. Recent evidence suggests that a principal target of ACE inhibitor action is at the tissue sites. Pharmacokinetic properties of various ACE inhibitors indicate that there are differences in their binding characteristics for tissue ACE. Clinical studies comparing the effects of antihypertensives (especially ACE inhibitors) on endothelial function suggest differences. More comparative experimental and clinical studies should address the significance of these drug differences and their impact on clinical events

    Medieval phenomena in a modern age A study of six contemporary cases of stigmatia and reactions to them

    Get PDF
    SIGLEAvailable from British Library Document Supply Centre-DSC:DXN021959 / BLDSC - British Library Document Supply CentreGBUnited Kingdo

    Blockade of AT 1

    No full text

    Baseline Patient Characteristics.

    No full text
    <p>SD – standard deviation, M – Male, F – Female, HTN – hypertension, ESRD – end stage renal disease,</p><p>DM – diabetes mellitus, GN – glomerulonephritis (includes IgA, Goodpasture's, Immunofibrillary), Y/N – yes/no,</p><p>AVF – arteriovenous fistula, AVG – arteriovenous graft, CVC – central venous catheter, kgs – kilograms.</p

    Results of the Intervention Phases; Non-Normally Distributed Data.

    No full text
    <p>* 7 samples had chromatographic interference - lab unable to do analysis, 2 patients withdrew from the study;</p><p>** 2 patients withdrew from the study, 2 samples were missed,</p><p>***started to measure these after the first 5 patients were already enrolled, 2 patients withdrew from the study.</p
    corecore